Incyte Corporation

Articles by Incyte Corporation

Approaching Nonsegmental Vitiligo with a Focus on the Immune-Mediated Aspects of the Disease and a New Treatment Option to Consider

ByIncyte Corporation

August 30th 2022

Latest Updated Articles

Approaching Nonsegmental Vitiligo with a Focus on the Immune-Mediated Aspects of the Disease and a New Treatment Option to Consider
August 30th 2022

Trending on Dermatology Times

Updated HS Guidelines Emphasize Biologics and Early Intervention

Dermatology Times Monthly FDA and Pipeline Review: October 2026

Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year

Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients

PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies